Trial Profile
A Prospective, Open-label, Randomized Trial Comparing Prograf and Neoral Use in Kidney Transplant Recipients of Hispanic Ethnicity.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Ciclosporin (Primary) ; Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 24 Sep 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 29 Sep 2009 New trial record